Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Genomic predictors of treatment response in prostate cancer
Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017
Impact of mutational profile at diagnosis for MDS/CML
Dr Guillermo Montalban Bravo - MD Anderson Cancer Center, Houston, USA
Impact of mutational profile at diagnosis for MDS/CML ( Dr Guillermo Montalban Bravo - MD Anderson Cancer Center, Houston, USA )
24 Jun 2017
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refrac...
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
The recent past and near future of drug approvals in Europe
Prof Filippo de Braud - Istituto Nazionale dei Tumori, Milan, Italy
The recent past and near future of drug approvals in Europe ( Prof Filippo de Braud - Istituto Nazionale dei Tumori, Milan, Italy )
19 Jun 2017
Cancer and the workplace
Prof Diana Kloss - Manchester University, Manchester, UK
Cancer and the workplace ( Prof Diana Kloss - Manchester University, Manchester, UK )
19 Jun 2017
Europa Uomo - improving prostate cancer patients quality of life across Europe
Prof Louis Denis - Europa Uomo, Belgium
Europa Uomo - improving prostate cancer patients quality of life across Europe ( Prof Louis Denis - Europa Uomo, Belgium )
19 Jun 2017
ECCO: making cross-border cancer healthcare a reality
Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECCO: making cross-border cancer healthcare a reality ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
19 Jun 2017
Clinical potential of trastuzumab biosimilar CTP6
Prof Francisco Esteva - NYU Langone Medical Center, New York, USA
Clinical potential of trastuzumab biosimilar CTP6 ( Prof Francisco Esteva - NYU Langone Medical Center, New York, USA )
8 Jun 2017
Hypogonadism following cisplatin treatment of testicular cancer
Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis...
Hypogonadism following cisplatin treatment of testicular cancer ( Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis, USA )
2 Jun 2017
Role of histologic regression in melanoma
Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy
Role of histologic regression in melanoma ( Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy )
18 May 2017
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
Dr Christian Blank - Netherlands Cancer Institute, Amsterdam, The Netherlands
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma ( Dr Christian Blank - Netherlands Cancer Institute, Amsterdam, The Netherlands )
18 May 2017
Duration of checkpoint inhibitor therapy
Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Duration of checkpoint inhibitor therapy ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
17 May 2017